Tags

Type your tag names separated by a space and hit enter

Combinational effect of topotecan and octreotide on murine leukemia cells in vivo and in vitro.
J BUON. 2006 Jul-Sep; 11(3):323-7.JB

Abstract

PURPOSE

The activity of topotecan (TPT) against a number of hematological malignancies is now notably increased. TPT is a drug which inhibits the DNA enzyme topoisomerase I (topo I), thereby leading to the induction of tumor cell apoptosis. On the other hand, octreotide (OCT) is a synthetic analogue of somatostatin, which can induce apoptosis and antiproliferative effects on various human tumor cell lines, human xenografts and animal tumors, as well as on lymphoproliferative neoplasms. Hereby, we studied the effects of TPT and OCT, and their combination in the treatment of the rodent P388 lymphocytic leukemia, in vitro and in vivo.

MATERIALS AND METHODS

Cell cultures of P388 lymphocytic leukemia cells, as well as BDF1 male and female mice implanted with the P388 leukemia cells, were used for the in vitro and in vivo evaluation of the antineoplastic activity of OCT and TPT.

RESULTS

A significant increase of antileukemic activity of the combined treatment with both TPT and OCT was demonstrated. These results suggest that OCT enhances the effectiveness of TPT in the treatment of leukemia.

CONCLUSION

Our results indicate that the combination of OCT with TPT in the treatment of hematological neoplasias is effective, and represents an interesting addition to the future therapeutic options, because os its mechanism of action and its toxicity profile.

Authors+Show Affiliations

Laboratory of Cell Culture - Molecular Modeling & Drug Design, Symeonidio Research Center, Theagenio Cancer Hospital, Thessaloniki, Greece.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

17309157

Citation

Dalezis, P, et al. "Combinational Effect of Topotecan and Octreotide On Murine Leukemia Cells in Vivo and in Vitro." Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology, vol. 11, no. 3, 2006, pp. 323-7.
Dalezis P, Geromichalos GD, Voyatzi S, et al. Combinational effect of topotecan and octreotide on murine leukemia cells in vivo and in vitro. J BUON. 2006;11(3):323-7.
Dalezis, P., Geromichalos, G. D., Voyatzi, S., Trafalis, D., Athanassiou, A. E., Koutsilieris, M., & Papageorgiou, A. (2006). Combinational effect of topotecan and octreotide on murine leukemia cells in vivo and in vitro. Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology, 11(3), 323-7.
Dalezis P, et al. Combinational Effect of Topotecan and Octreotide On Murine Leukemia Cells in Vivo and in Vitro. J BUON. 2006 Jul-Sep;11(3):323-7. PubMed PMID: 17309157.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Combinational effect of topotecan and octreotide on murine leukemia cells in vivo and in vitro. AU - Dalezis,P, AU - Geromichalos,G D, AU - Voyatzi,S, AU - Trafalis,D, AU - Athanassiou,A E, AU - Koutsilieris,M, AU - Papageorgiou,A, PY - 2007/2/20/pubmed PY - 2007/3/28/medline PY - 2007/2/20/entrez SP - 323 EP - 7 JF - Journal of B.U.ON. : official journal of the Balkan Union of Oncology JO - J BUON VL - 11 IS - 3 N2 - PURPOSE: The activity of topotecan (TPT) against a number of hematological malignancies is now notably increased. TPT is a drug which inhibits the DNA enzyme topoisomerase I (topo I), thereby leading to the induction of tumor cell apoptosis. On the other hand, octreotide (OCT) is a synthetic analogue of somatostatin, which can induce apoptosis and antiproliferative effects on various human tumor cell lines, human xenografts and animal tumors, as well as on lymphoproliferative neoplasms. Hereby, we studied the effects of TPT and OCT, and their combination in the treatment of the rodent P388 lymphocytic leukemia, in vitro and in vivo. MATERIALS AND METHODS: Cell cultures of P388 lymphocytic leukemia cells, as well as BDF1 male and female mice implanted with the P388 leukemia cells, were used for the in vitro and in vivo evaluation of the antineoplastic activity of OCT and TPT. RESULTS: A significant increase of antileukemic activity of the combined treatment with both TPT and OCT was demonstrated. These results suggest that OCT enhances the effectiveness of TPT in the treatment of leukemia. CONCLUSION: Our results indicate that the combination of OCT with TPT in the treatment of hematological neoplasias is effective, and represents an interesting addition to the future therapeutic options, because os its mechanism of action and its toxicity profile. SN - 1107-0625 UR - https://www.unboundmedicine.com/medline/citation/17309157/Combinational_effect_of_topotecan_and_octreotide_on_murine_leukemia_cells_in_vivo_and_in_vitro_ L2 - https://antibodies.cancer.gov/detail/CPTC-TOP1-1 DB - PRIME DP - Unbound Medicine ER -